| Next biotechnological plants for addressing global challenges: The contribution of transgenesis and new breeding techniques AE Ricroch, J Martin-Laffon, B Rault, VC Pallares, M Kuntz New biotechnology 66, 25-35, 2022 | 36 | 2022 |
| Patient and Physician Preferences for Fixed-Duration Vs Treatment to Progression Chronic Lymphocytic Leukemia (CLL) Treatments: Results from a Multi-Country Discrete Choice … B Sile, D Horchi, B Rault, E Mulvihill, K Beusterien, A Teschemaker, ... Blood 142, 6528, 2023 | 1 | 2023 |
| Prevalence of Chronic Hand Eczema in adults: A cross-sectional survey of over 60,000 respondents in the general population in Canada, France, Germany, Italy, Spain, and the … C Apfelbacher, A Bewley, S Molin, MC Fargnoli, AM Giménez-Arnau, ... British Journal of Dermatology, ljaf020, 2025 | | 2025 |
| Description of Feelings, Perception, and Experience Before and After Switching from IV Daratumumab to the SC Form: A Mixed-Method, Cross-Sectional Survey in Multiple Myeloma … V Magarotto, J Thevenon, K Morgan, S Ten Seldam, W Iraqi, X Guillaume, ... Patient preference and adherence, 1857-1871, 2024 | | 2024 |
| RWD88 The Psychosocial Impact of Chronic Hand Eczema: Findings From the Population-Based Check (Chronic Hand Eczema Epidemiology, Care, and Knowledge of Real-Life Burden) Study A Bewley, S Molin, MN Crépy, MC Fargnoli, C Apfelbacher, P Le Calvé, ... Value in Health 27 (12), S590, 2024 | | 2024 |
| Understanding Patient and Physician Perceptions Regarding Treatment-Related Adverse Events in First-Line Chronic Lymphocytic Leukemia (CLL) B Sile, D Horchi, B Rault, E Mulvihill, K Beusterien, K Stewart, ... Blood 142, 6546, 2023 | | 2023 |
| PB2679: MIXED-METHOD, CROSS-SECTIONAL SURVEY TO DESCRIBE FEELINGS, PERCEPTION, AND EXPERIENCE OF MULTIPLE MYELOMA PATIENTS WHO SWITCHED FROM INTRAVENOUS DARATUMUMAB TO THE … V Magarotto, J Thevenon, K Morgan, S Ten Seldam, W Iraqi, X Guillaume, ... HemaSphere 7 (Suppl), e8967582, 2023 | | 2023 |
Victor PALLARESZweryfikowany adres z agroparistech.fr